Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVAS
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal dose of intravenous cyclophosphamide during remission induction therapy in ANCA-associated vasculitis: A retrospective cohort study of J-CANVAS
Authors
Keywords
-
Journal
Modern Rheumatology
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2023-10-07
DOI
10.1093/mr/road099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update
- (2023) Bernhard Hellmich et al. ANNALS OF THE RHEUMATIC DISEASES
- Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study
- (2023) Satoshi Omura et al. RHEUMATOLOGY
- Association between different infection profiles and one-year outcomes in ANCA-associated vasculitis: a retrospective study with monthly infection screening
- (2022) Tingting Xu et al. RMD Open
- Incidence and temporal trend in risk factors of severe infections in ANCA-Glomerulonephritis patients.
- (2021) Pierre Jourdain et al. Kidney International Reports
- Avacopan for the Treatment of ANCA-Associated Vasculitis
- (2021) David R.W. Jayne et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2021) Sharon A. Chung et al. ARTHRITIS CARE & RESEARCH
- Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study
- (2020) Jens Rathmann et al. RHEUMATOLOGY
- Predicting severe infection and effects of hypogammaglobulinaemia during therapy with rituximab in rheumatic and musculoskeletal diseases
- (2019) Md Yuzaiful Md Yusof et al. Arthritis & Rheumatology
- T-cell modulation by cyclophosphamide for tumour therapy
- (2018) Ellyn Hughes et al. IMMUNOLOGY
- Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study
- (2018) Liu Yang et al. BMC Nephrology
- Dose translation between laboratory animals and human in preclinical and clinical phases of drug development
- (2018) Anroop Nair et al. DRUG DEVELOPMENT RESEARCH
- Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study
- (2018) Dimitri Titeca-Beauport et al. BMC Nephrology
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
- (2016) M Yates et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy
- (2015) A. Visentin et al. HAEMATOLOGICA
- Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy
- (2015) A. Visentin et al. HAEMATOLOGICA
- Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty-Five Years or Older: Results of a Multicenter, Open-Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide-Based Induction Therapy
- (2015) Christian Pagnoux et al. Arthritis & Rheumatology
- Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis
- (2013) Kirsten de Groot ANNALS OF INTERNAL MEDICINE
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
- (2012) J. C. Jennette et al. ARTHRITIS AND RHEUMATISM
- Long-term patient survival in ANCA-associated vasculitis
- (2010) O. Flossmann et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis
- (2009) M. A. Little et al. ANNALS OF THE RHEUMATIC DISEASES
- Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
- (2008) C Mukhtyar et al. ANNALS OF THE RHEUMATIC DISEASES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started